Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Capital Expenditures (2017 - 2025)

STRATA Skin Sciences' Capital Expenditures history spans 12 years, with the latest figure at $1.4 million for Q4 2025.

  • On a quarterly basis, Capital Expenditures fell 16.26% to $1.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.5 million, a 10.27% decrease, with the full-year FY2025 number at $1.5 million, down 10.27% from a year prior.
  • Capital Expenditures hit $1.4 million in Q4 2025 for STRATA Skin Sciences, up from -$40000.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for SSKN hit a ceiling of $1.8 million in Q1 2023 and a floor of -$1.1 million in Q3 2024.
  • Historically, Capital Expenditures has averaged $775600.0 across 5 years, with a median of $733000.0 in 2021.
  • Biggest five-year swings in Capital Expenditures: skyrocketed 163.92% in 2023 and later crashed 451.55% in 2024.
  • Tracing SSKN's Capital Expenditures over 5 years: stood at $1.1 million in 2021, then soared by 50.35% to $1.7 million in 2022, then grew by 1.12% to $1.7 million in 2023, then fell by 4.77% to $1.6 million in 2024, then dropped by 16.26% to $1.4 million in 2025.
  • Business Quant data shows Capital Expenditures for SSKN at $1.4 million in Q4 2025, -$40000.0 in Q3 2025, and -$61000.0 in Q2 2025.